secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vivos Therapeutics, Inc. (VVOS)
CIK:        0001716166
Form:       8-K
Filed at:   2026-01-20T23:59:59+00:00
Accession:  0001493152-26-002844
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vivos Therapeutics raises $4.6M via warrant exercise and issues new warrants for 3.96M shares
--------------------------------------------------------------------------------

- Gross proceeds of ~$4.6M from immediate cash exercise of existing warrants at reduced price of $2.34/share.
- Issued Series A (5-yr) and Series B (24-mo) warrants to purchase up to 3,964,712 shares at $2.09/share.
- Must file resale registration for new warrant shares by Feb 14, 2026; effective by Mar 16 or Apr 15 if SEC review.
- Placement agent H.C. Wainwright paid 7% cash fee and received warrants for 138,765 shares at $2.925/share.
- Until Feb 19, 2026, company restricted from issuing additional shares or filing registration statements.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716166/000149315226002844/0001493152-26-002844-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716166/000149315226002844/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-002844

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer